U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06820645) titled 'Calcium Administration in Life-saving Management During Massive Hemorrhage' on Jan. 13.
Brief Summary: This study evaluates the feasibility of conducting a larger study on the impact of treating massive hemorrhage with calcium in trauma patients. Patients undergoing the Massive Hemorrhage Protocol (MHP) will be randomly assigned to receive either calcium gluconate or placebo drug after every 4 packs of units of RBCs received during the MHP.
Study Start Date: May 01, 2025
Study Type: INTERVENTIONAL
Condition:
Massive Hemorrhage
Trauma
Hypocalcemia
Intervention:
DRUG: calcium gluconate
3g IV or IO calcium gluconate.
DRUG: Cont...